Copertina

Image‐based remote evaluation of PASI scores with psoriasis by the YOLO‐v4 algorithm

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Heng Yin, Hui Chen, Wei Zhang, Jing Zhang, Tao Cui, Yunpeng Li, Nan Yu, Yingyao Yu, Hai Long, Rong Xiao, Yuwen Su, Yaping Li, Guiying Zhang, Yixin Tan, Haijing Wu, Qianjin Lu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The required absolute PASI score to achieve DLQI remission
di: Emi Nishida, et al.
Pubblicazione: (2025)

Topical BCl‐2 inhibitor (ABT‐737) attenuates skin photoaging in mice
di: Bingyi Yang, et al.
Pubblicazione: (2024)

Response to ‘Enhancing multimodal deep learning for improved precision and efficiency in medical diagnostics’
di: Kaili Chen, et al.
Pubblicazione: (2024)

Correction to “Automatic evaluation of nail psoriasis severity index using deep learning algorithm”
Pubblicazione: (2024)

A novel presentation of pheohyphomycosis caused by Exophiala jeanselmei
di: Shuaihantian Luo, et al.
Pubblicazione: (2024)

The impacts of biologic treatment on metabolic profiling in psoriasis
di: Sichun Deng, et al.
Pubblicazione: (2024)

Histone modification in psoriasis: Molecular mechanisms and potential therapeutic targets
di: Ruifeng Liu, et al.
Pubblicazione: (2024)

Apremilast treatment for pediatric inverse psoriasis
di: Jun Wang, et al.
Pubblicazione: (2024)

Sclerosing cholangitis exacerbated by widespread pustular psoriasis
di: Akane Ogaya, et al.
Pubblicazione: (2024)

Increased neutrophil‐derived IL‐17A identified in generalized pustular psoriasis
di: Yu Lan, et al.
Pubblicazione: (2024)

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study
di: Weiyu Ye, et al.
Pubblicazione: (2025)

Efficacy and safety of epidural block with lidocaine for refractory severe plaque psoriasis: An open‐label pilot study in real world setting
di: Xin Xu, et al.
Pubblicazione: (2024)

Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes
di: Yuyue Zuo, et al.
Pubblicazione: (2024)

Prospective evaluation of cardiovascular risk and mortality in patients with psoriasis: An American population‐based study
di: Junyan Kan, et al.
Pubblicazione: (2024)

Acquired diffuse palmoplantar erythema with keratoderma in Chinese patients with pustular psoriasis: A predictor for IL36 receptor antagonist c.115+6T>C mutation?
di: Francis Li‐Tien Hsu, et al.
Pubblicazione: (2024)

Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis
di: Diamant Thaçi
Pubblicazione: (2025)

eIF4E plays the role of a pathogenic gene in psoriasis, and the inhibition of eIF4E phosphorylation ameliorates psoriasis‐like skin damage
di: Ruijie Wang, et al.
Pubblicazione: (2024)

¿Qué es la psoriasis?
Pubblicazione: (2025)

Asia‐Pacific consensus recommendations on the management of generalized pustular psoriasis
di: Siew Eng Choon, et al.
Pubblicazione: (2024)

From Skin to Lungs: The Causal Pathways Linking Skin Microbiota and Asthma
di: Jiaqi Chen, et al.
Pubblicazione: (2025)

Umbilical psoriasis is not relevant to psoriatic arthritis
di: Maki Takada, et al.
Pubblicazione: (2024)

Comparative effects of biologics on anxiety and depression symptoms in psoriasis
di: Yuxiong Jiang, et al.
Pubblicazione: (2025)

Disagreement between physicians' and patients' assessment of disease activity in psoriasis: The SPEECH registry study
di: Yuxiong Jiang, et al.
Pubblicazione: (2024)

Systemic therapy for psoriasis and the risk of cutaneous infections
di: Yuko Higashi, et al.
Pubblicazione: (2024)

Biological agent exerts therapeutic effects by reversing abnormalities in amino acid metabolic pathways in psoriasis
di: Haijun Miao, et al.
Pubblicazione: (2024)

Influential Factors in the Efficacy and Safety of Hemoporfin‐Mediated Photodynamic Therapy for Facial Port‐Wine Stains
di: Ruixuan You, et al.
Pubblicazione: (2025)

Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation for Improving Clinical Signs of Facial Skin Aging
di: Yi Luo, et al.
Pubblicazione: (2026)

Biologic treatment outcomes in generalized pustular psoriasis of pregnancy: A systematic review
di: YuFei Wang, et al.
Pubblicazione: (2024)

Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis
di: Jue Tang, et al.
Pubblicazione: (2024)

Regional differences in the prevalence of generalized pustular psoriasis in Japan
di: Hideki Fujita, et al.
Pubblicazione: (2024)

Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab
di: Ken Okamura, et al.
Pubblicazione: (2024)

Predictive factors for responders to deucravacitinib treatment in patients with psoriasis
di: Teppei Hagino, et al.
Pubblicazione: (2024)

Can imiquimod really provoke psoriasis?
di: Katinka Ónodi, et al.
Pubblicazione: (2024)

Targeting the NLRP3 inflammasome in psoriasis
di: Xiuhui Chen, et al.
Pubblicazione: (2024)

Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?
di: Marina Talamonti, et al.
Pubblicazione: (2024)

Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
di: Amin Yao, et al.
Pubblicazione: (2024)

Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib
di: Tubanur Çetinarslan, et al.
Pubblicazione: (2024)

Prevalence and psychosocial correlates of apathy in psoriasis: A cross‐sectional study
di: Adam C. Yu, et al.
Pubblicazione: (2026)

Increased circulating interleukin 36γ DNA copies in psoriasis
di: Kazumi Urata, et al.
Pubblicazione: (2025)

A case of generalized pustular psoriasis following discontinuation of apremilast
di: Tatsuya Yamashita, et al.
Pubblicazione: (2024)